![Adam Sinding Steensberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adam Sinding Steensberg
Chief Executive Officer at
ZEALAND PHARMA A/S
Net worth: 7 M $ as of 30/04/2026
Profile
Adam Sinding Steensberg currently works at Zealand Pharma A, as President & Chief Executive Officer from 2022 and The Danish Business Authority, as Chief Executive Officer from 2019.
Dr. Steensberg also formerly worked at Beta Bionics, Inc., as Director, Dansk Biotek, as Director, Cessatech A, as Independent Director, Novo Nordisk A, as Medical Director from 2006 to 2010, and Rigshospitalet, as Clinician.
Dr. Steensberg received his doctorate degree from the University of Copenhagen and Masters Business Admin degree in 2015 from International Institute for Management Development.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2025 | 1,43,559 ( 0.2% ) | 7 M $ | 30/04/2026 |
Adam Sinding Steensberg active positions
| Companies | Position | Start |
|---|---|---|
| ZEALAND PHARMA A/S | Chief Executive Officer | 30/03/2022 |
The Danish Business Authority
 The Danish Business Authority National AgencyGovernment Provides information on rules and registrations to foreign service providers | Chief Executive Officer | 01/03/2019 |
Former positions of Adam Sinding Steensberg
| Companies | Position | End |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/09/2010 |
| CESSATECH A/S | Director/Board Member | - |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research | Director/Board Member | - |
| BETA BIONICS, INC. | Director/Board Member | - |
Rigshospitalet
 Rigshospitalet Hospital/Nursing ManagementHealth Services Provides medical services | Corporate Officer/Principal | - |
Training of Adam Sinding Steensberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
42
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dansk Biotek
Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research | Commercial Services |
Rigshospitalet
Rigshospitalet Hospital/Nursing ManagementHealth Services Provides medical services | Health Services |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
The Danish Business Authority
The Danish Business Authority National AgencyGovernment Provides information on rules and registrations to foreign service providers | Government |
Cessatech A/S
 Cessatech A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for children for the treatment of pediatric acute pain | Health Technology |
- Stock Market
- Insiders
- Adam Sinding Steensberg
